NSE
NGLFINE

NGL Fine-Chem Limited

Drug Manufacturers-General
Healthcare

Prices are adjusted according to historical splits.

NGL Fine-Chem Limited Stock Price

Vitals

Today's Low:
₹1928.15
Today's High:
₹2031.45
Open Price:
₹2003.1
52W Low:
₹1160.3182
52W High:
₹2425.1001
Prev. Close:
₹1997.4
Volume:
1457

Company Statistics

Market Cap.:
₹14.17 billion
Book Value:
360.227
Revenue TTM:
₹2.84 billion
Operating Margin TTM:
11.1%
Gross Profit TTM:
₹1.29 billion
Profit Margin:
10.03%
Return on Assets TTM:
5.1%
Return on Equity TTM:
9.63%

Company Profile

NGL Fine-Chem Limited had its IPO on under the ticker symbol NGLFINE.

The company operates in the Healthcare sector and Drug Manufacturers-General industry. NGL Fine-Chem Limited has a staff strength of 396 employees.

Stock update

Shares of NGL Fine-Chem Limited opened at ₹2003.1 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹1928.15 - ₹2031.45, and closed at ₹1961.6.

This is a -1.79% slip from the previous day's closing price.

A total volume of 1,457 shares were traded at the close of the day’s session.

In the last one week, shares of NGL Fine-Chem Limited have slipped by -9.28%.

NGL Fine-Chem Limited's Key Ratios

NGL Fine-Chem Limited has a market cap of ₹14.17 billion, indicating a price to book ratio of 4.8783 and a price to sales ratio of 3.4676.

In the last 12-months NGL Fine-Chem Limited’s revenue was ₹2.84 billion with a gross profit of ₹1.29 billion and an EBITDA of ₹428.64 million. The EBITDA ratio measures NGL Fine-Chem Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, NGL Fine-Chem Limited’s operating margin was 11.1% while its return on assets stood at 5.1% with a return of equity of 9.63%.

In Q2, NGL Fine-Chem Limited’s quarterly earnings growth was a positive 1539.3% while revenue growth was a positive 10%.

NGL Fine-Chem Limited’s PE and PEG Ratio

Forward PE
0
Trailing PE
49.7463
PEG

Its diluted EPS in the last 12-months stands at ₹46.12 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into NGL Fine-Chem Limited’s profitability.

NGL Fine-Chem Limited stock is trading at a EV to sales ratio of 3.3835 and a EV to EBITDA ratio of 22.8298. Its price to sales ratio in the trailing 12-months stood at 3.4676.

NGL Fine-Chem Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 3.73%.

Balance sheet and cash flow metrics

Total Assets
₹2.87 billion
Total Liabilities
₹582.92 million
Operating Cash Flow
₹0
Capital Expenditure
₹0
Dividend Payout Ratio
3.73%

NGL Fine-Chem Limited ended 2024 with ₹2.87 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹2.87 billion while shareholder equity stood at ₹2.23 billion.

NGL Fine-Chem Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹582.92 million in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹78.28 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹20.73 million.

NGL Fine-Chem Limited’s total current assets stands at ₹1.63 billion while long-term investments were ₹0 and short-term investments were ₹496.74 million. Its net receivables were ₹658.71 million compared to accounts payable of ₹245.86 million and inventory worth ₹269.93 million.

In 2024, NGL Fine-Chem Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, NGL Fine-Chem Limited paid ₹0.04 in dividends in 2024.

Other key metrics

Current Trading Price
₹1961.6
52-Week High
₹2425.1001
52-Week Low
₹1160.3182
Analyst Target Price

NGL Fine-Chem Limited stock is currently trading at ₹1961.6 per share. It touched a 52-week high of ₹2425.1001 and a 52-week low of ₹2425.1001. Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was ₹2043.24 and 200-day moving average was ₹1639.37 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 7463% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About NGL Fine-Chem Limited

The stock symbol (also called stock or share ticker) of NGL Fine-Chem Limited is NGLFINE

The IPO of NGL Fine-Chem Limited took place on

Similar Industry Stocks (Drug Manufacturers-General)

Last Price
Chg
Chg%
₹12.16
0.05
+0.41%
Healixa Inc (EMOR)
₹0.26
0.01
+4%
₹15835.55
-466.6
-2.86%
₹791.2
-59.9
-7.04%
₹66.83
-2.36
-3.41%
₹3580.6
101.25
+2.91%
₹27.95
-0.16
-0.57%
₹222.85
-11.1
-4.74%
₹708.95
-10.8
-1.5%
Tegna Inc (TGNA)
₹15.92
0.53
+3.44%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
₹0.14
0.07
+100%
₹0.12
0.04
+45.29%
₹0.96
0.05
+5.4%
₹1.34
-0.35
-20.71%
Humbl Inc (HMBL)
₹0
0
0%

Top Gainers

Last Price
Chg
Chg%
₹0
0
+172200%
₹0
0
+51200%
₹283
280.03
+9428.62%
₹11.2
10.57
+1667.68%
Latch Inc (LTCHW)
₹0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
₹0.19
-123.15
-99.85%
₹0
-0.11
-99.55%
₹0
-0
-97.96%
₹0
-0.01
-93.94%
₹0.01
-0.06
-92.24%

About

NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide. It offers active pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine HCl, S-methoprene, praziquantel, toltrazuril, decoquinate, flunixin meglumine, carprofen, fenbendazole, amitraz, xylazine hydrochloride, and marbofloxacin for animal health applications; and nitazoxanide and atovaquone for human health applications. The company provides various intermediate products and specialty chemicals; and finished dosage forms in granules and tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.

Address